bioMérieux S.A. (EPA:BIM)
France flag France · Delayed Price · Currency is EUR
70.60
-1.25 (-1.74%)
Jul 31, 2026, 11:55 AM CET

bioMérieux Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, bioMérieux stock has a consensus rating of "Hold" and an average price target of €79.04. The average 1-year stock price forecast is 11.95% higher than the current stock price, while the lowest is €64.00 (-9.35%) and the highest is €100.00 (+41.64%).

Price Target: €79.04 (+11.95%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price€64.00€79.04€79.00€100.00
Change-9.35%+11.95%+11.90%+41.64%

Analyst Ratings

The average analyst rating for bioMérieux stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy543333
Buy111111
Hold789899
Sell000000
Strong Sell000011
Total131313121414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Deutsche Bank
Deutsche Bank
Hold
Maintains
€78.00€75.00
HoldMaintains€78.00€75.00+6.23%Jul 30, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
€80.00
HoldReiterates€80.00+13.31%Jul 29, 2026
UBS
UBS
Hold
Maintains
€80.00€78.00
HoldMaintains€80.00€78.00+10.48%Jul 29, 2026
Kepler Capital
Kepler Capital
Buy
Maintains
€85.00
BuyMaintains€85.00+20.40%Jun 25, 2026
Morgan Stanley
Morgan Stanley
Sell
Downgrades
€100.00€64.00
SellDowngrades€100.00€64.00-9.35%Jun 23, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.12B
from 4.07B
Increased by 1.34%
Revenue Next Year
4.34B
from 4.12B
Increased by 5.17%
EPS This Year
4.34
from 4.64
Decreased by -6.43%
EPS Next Year
4.66
from 4.34
Increased by 7.44%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
3.38B3.59B3.67B3.98B4.07B4.12B
Revenue Growth
8.27%6.31%2.39%8.31%2.26%1.34%
Gross Profit
2.00B2.01B2.06B2.22B2.31B2.29B
Gross Margin
59.26%55.97%55.99%55.66%56.73%55.63%
Operating Income
813.50M613.00M569.00M637.90M694.80M662.87M
Net Income
601.10M452.40M357.60M432.20M397.50M482.39M
EPS
----4.644.34
EPS Growth
----22.16%-6.43%
Forward PE
31.2525.4823.6023.0522.6216.26
Dividend / Share
0.850.850.850.900.981.05
Dividend Growth
---5.88%8.89%6.67%
Free Cash Flow
389.05M206.36M152.25M297.69M615.78M450.53M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High4.2B
Avg4.1B
Low4.1B

Revenue Growth

Revenue Growth202620272028
High
2.8%
Avg
1.3%
Low
0.6%

EPS Forecast

EPS202620272028
High4.59
Avg4.34
Low4.04

EPS Growth

EPS Growth202620272028
High
-1.1%
Avg
-6.4%
Low
-12.9%